Cello Health

256 W. 38th Street, 15th Floor

New York, NY 10018

Telephone: 646-837-8151

790 Township Line Road, Suite 200

Yardley, PA 19067

Telephone: 215-504-5082

Email: [email protected]

Website: cellohealth.com

 

 

Cello Health is a global organization composed of three distinct capabilities: communications, market research or insight, and consulting.

“We increasingly find that client challenges are best served with a fusion of this expertise, which enables Cello Health to develop more appropriate and valuable integrated solutions that unlock the potential of assets, brands, and organizations,” executives say. “With a purpose-built organization that focuses on these three specialties, the solution can be delivered seamlessly by a single provider with greater bandwidth and flexibility, a value-added blend of relevant skills, and the ability to look at client challenges through multiple lenses. Teams from each of these “best in class” capabilities partner with clients to help them make critical business decisions, fusing together strategic guidance and input, insights, and scientific understanding.”

According to network leaders, in 2015, Cello Health added clients ranging from big pharma through midsize and small companies to a roster that includes clients focused in rare diseases and devices and diagnostics.

 

The year’s accomplishments

Cello Health US expanded its operation in 2015 with the addition of an office in the Boston area. Executives say integrated teams now operate in five offices in the United States: Philadelphia, New York, Chicago, San Francisco, and the newly added Boston area office, providing clients with depth in and blends of resources across the country.

“We expanded the Philadelphia office, historically the home of the communications business, at the start of 2015; the office suites at this location now include consultants in addition to communications specialists,” executives say. “The New York and San Francisco offices also co-house colleagues from across capabilities as a result of 2015 growth initiatives.”

 

Structure and services

According to network leaders, Cello Health’s services, both within an individual capability and when combined as an integrated solution, can be applied across the entire product life cycle.

“However, consistent with the fact that several thousand U.S. companies have assets in Phase II, our U.S. teams often provide services and solutions targeted to early-stage drug development,” executives say. “These services can be applied as early as the point in time when a client is considering acquiring an asset, or certainly from the start of Phase II in the drug development process. Start-up biopharma organizations and companies with an initial I or II assets are notable beneficiaries of the early-stage services that we currently offer and plan on extending in 2016.”

Experienced teams leverage a combination of evidence analysis, market-based insights, and proven processes to help client partners navigate clinical and commercial development pathways, providing specialized offerings including evidence-based market assessments, market-driven primary market research, forecasts and valuations, and indication prioritization, executives say.

For example, Promedica offers First Look, a custom, primary research–based, commercial assessment that provides market-driven insight to inform product development and partnering or investment decisions. “From the earliest stages, our extensive indication and therapeutic area experience helps Cello Health’s clients look ‘over the horizon’ in order to develop defendable strategic insights that can facilitate internal decision making around critical commercial options,” executives say. 

Cello Health BioConsulting provides strategic guidance and insight to help clients navigate the early drug development and commercialization process, and seasoned practitioners and advisors from within the group have proven track records of working with start-ups and small- and medium-cap companies, executives say.

Cello Health BioConsulting teams focus on four key practices: Early Asset Development, a structured approach that enables teams to focus on critical issues and decisions that are needed to successfully develop new assets; Launch Planning, launch optimization and cross-functional planning that prepares companies to successfully bring new products to market; Brand and Portfolio Strategy, assisting clients with competitive positioning that uses the organization’s CompetitoRoom process, brand planning, and product strategy to maximize product potential throughout the life cycle; and Business Development, providing clients with the analysis and data needed to forecast their revenue, determine their needed investments, and assess the value of their products.

In 2015, this group provided the basis for the opening of the Boston area office and, with growth in headcount, now also operates in New York and Philadelphia, executives say.

Cello Health Insight actively engages with health care practitioners, patients, caregivers, and payers to deliver customized qualitative and quantitative market research, with a specialized focus on patient insights, behavioral insights, and rare diseases, executives say. Experienced teams based in New York, Chicago, and San Francisco provide specialist consultancy through four core practices: Qualitative, focused on drivers of behavior change using innovative processes and interpretation techniques; Intelligent Quantitative, supporting strategic and tactical decision making at key stages of an asset’s life cycle; Patient and Caregiver Research, tracing the patient journey from pre-diagnosis through disease management while understanding the full burden of disease; and Digital Mobile Research, proprietary online patient and health care provider communities, social media listening, and digital patient pathway maps that help clients leverage the latest technologies in order to answer specific questions and address business challenges.

According to network leaders, San Francisco–based Promedica, acquired at the very end of 2014, was acclimated into the Cello Health family during 2015.  The organization, now in its second year within Cello Health, specializes in primary market research, with a focus on new product planning; life cycle management; and business development support for biotech, pharma, diagnostics, and device companies and the investment community.  “In 2015, we added colleagues from other capabilities in the Promedica office, thus establishing a platform on which we are now continuing to build our cross-capability resources on the West Coast,” executives say.

Cello Health Communications added representation in California in 2015 and now operates on both coasts, offering in-house teams that are able to translate clinical evidence into impactful communications initiatives that resonate with health care practitioners, payers, and patients. 

“Our team of communications specialists now numbers 140 across the United States and the United Kingdom, partnering with client teams under the Cello Health Communications capability umbrella to help them demonstrate and substantiate the value of assets and brands throughout the development continuum using a comprehensive mix of strategic and tactical solutions,” executives say. “Experienced teams specialize in developing compelling, relevant core content to facilitate scientific exchange across the evidence-to-engagement spectrum – from data dissemination and strategic publications planning to medical education and peer-to-peer programming – to induce behavior change that is aligned with asset goals.

“When clients need help with creating their scientific story, Cello Health Communications teams conduct deep and robust desk research to uncover specific points of differentiation that resonates with stakeholders and drives commercial positioning.  As part of ongoing growth initiatives, public affairs and clinical and regulatory writing were formalized as service offerings in the United States in 2015.    Further, building on the strong communications platform in health economics and outcomes research of the U.S. business, payer research often conducted within Cello Health Insight, and the experience of the consulting team, the organization is also now able to provide a complete market access service with data analytics as a core element.

 

 

Philanthropy/citizenship

According to network leaders, Cello Health conducts a number of philanthropic initiatives, typically focused on the health and welfare needs of local communities.  Both the company and colleagues provide this support in donating time, consumer goods, or monetary donations, depending on the circumstance.  Beneficiaries regularly include local shelters and hunger relief organizations, and the company has now also instituted a Volunteer Time Off policy. Individuals from the San Francisco office routinely support Lucille Packard Children’s Hospital, Ronald McDonald House, and the Make-A-Wish Foundation.